Zheng Long

Mr. Zheng Long

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2025 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ZLZheng Long
Zheng Long
YQYujie Qiu
Yujie Qiu
ZLZhenghao Long
Zhenghao Long
ZJZicheng Jin
Zicheng Jin
Breast cancer is a major global public health concern and a major cause of cancer-related mortality. In 2020, 8.3% of the total breast cancer deaths worldwide were reported from China, which highlighted the need to understand the epidemiological trends of breast cancer within the country. Therefore, this study aimed to analyse the trends in the breast cancer burden in China from 1990 to 2021 and compare them with global trends to provide insights for future prevention and control strategies. Data were sourced from the Global Burden of Disease database 2021, which includes comprehensive information on the disease burden across 204 countries from 1990 to 2021. We analysed six key indicators: the mortality, prevalence, incidence, disability-adjusted life years, years lived with disability, and years of life lost. Age-standardized rates were analysed using the global age structure as a reference. Joinpoint regression was employed to assess the annual percentage change and average annual percentage change. In 2021, 3.75 million prevalent breast cancer cases, with 385,837 new breast cancer cases and 88,106 deaths due to breast cancer, were reported from China. The crude rates of the prevalence, incidence, mortality, disability-adjusted life years, years lived with disability, and years of life lost significantly increased in 2021 compared with 1990. The age-standardized rates per 100,000 women were 355.72 for prevalence (+ 103.22% from 1990), 37.00 for incidence (107.40%), 8.24 for mortality (-8.24%), 281.54 for disability-adjusted life years (-6.68%), 25.86 for years lived with disability (110.24%), and 255.69 for years of life lost (-11.62%). The burden of breast cancer has notably increased among the women above 40 years of age, peaking between the ages of 50 and 59 years, and the proportion of cases in women under 40 years has decreased. The age-standardized rate of the mortality, disability-adjusted life years, and years of life lost of breast cancer decreased slightly in China; however, the age-standardized rate of the incidence, prevalence, and years lived with disability exhibited an upward trend between 1990 and 2021, thereby highlighting the need to improve treatment outcomes and formulate better policies for the prevention and control of breast cancer in China.

13 February 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
YQYujie Qiu
Yujie Qiu
ZLZhenghao Long
Zhenghao Long
ZLZheng Long
Zheng Long
To analyze the burden of dietary iron deficiency in China from 1990 to 2021. Using the results of the 2021 Global Burden of Disease (GBD 2021) study, this study analyzed the prevalence and disability adjusted life years (DALY) of dietary iron deficiency in China from 1990 to 2021. In 2021, the prevalence number of dietary iron deficiency was 795,910,75 (76,187,661−82,382,158), which decreased by 40.86% compared to that in 1990. The number of DALY were 1,689,209 (1,119,315–2,445,991), which decreased by 47.15% compared to that in 1990. The age-standardized prevalence rate (ASPR) and age-standardized DALY rate (ASDR) of dietary iron deficiency showed a downward trend from 1990 to 2021 (P < 0.05). From 1990 to 2021, the burden of dietary iron deficiency in China showed a downward trend, with the burden of females having a significantly higher than males, and the burden in females aged 20 to 49 years old increases significantly.

21 September 2023 in BMC Cancer
Verified
Journal Article
Open access
PDF file
YXYangyang Xu
Yangyang Xu
WLWei Liu
Wei Liu
ZLZheng Long
Zheng Long
LWLijun Wang
Lijun Wang
MZMaigeng Zhou
Maigeng Zhou
PYPeng Yin
Peng Yin
Background: Pancreatic cancer is a growing public health concern in China, and depicting it from different perspectives would provide a comprehensive understanding of its epidemiological characteristics. Methods: Data from the National Mortality Surveillance System (NMSS) in China was used to estimate the number of deaths, years of life lost (YLL), age-standardized mortality rate (ASMR) and age-standardized YLL rate in China, its provinces and urban-rural areas from 2005 to 2020. Joinpoint regression analysis was employed to explore the temporal trends of ASMR and age-standardized YLL rate. Decomposition analysis was conducted to assess the contribution of population growth, population aging and cause-specific mortality rate to the increment of pancreatic cancer deaths. Results: A total of 100,427 pancreatic cancer deaths and 2,166,355 pancreatic cancer related YLL were estimated in China in 2020. The overall ASMR significantly increased from 6.6/100 000 in 2005 to 7.4/100 000 in 2020, and was higher in men than that in women. Age-standardized YLL rate showed a similar trend. The mortality rates of pancreatic cancer were generally higher in northeast China than in southwest China. The highest ASMRs were found in Jilin, Zhejiang, Inner Mongolia and Anhui, and the lowest ones in Guangxi, Yunnan, Tibet, and Hainan. The disease burden due to pancreatic cancer presented a significant upward trend in rural areas and a downward trend in urban areas. Conclusions: The burden associated with pancreatic cancer had been increasing in China from 2005 to 2020. The escalating disease burden of pancreatic cancer in rural areas necessitates the implementation of effective control and prevention measures. Relevant provinces should pay greater attention to the prevailing of pancreatic cancer, particularly those exhibiting higher mortality rates.

7 April 2026 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ZLZheng Long
Zheng Long
FJFenghuan Jia
Fenghuan Jia
ZLZhenghao Long
Zhenghao Long
To analyze the burden of cataract in China from 1990 to 2021. Using the data of the 2021 Global Burden of Disease (GBD 2021) study, analyzed the the preval